Selection and immunomodulatory evaluation of lactic acid bacteria suitable for use as canine probiotics

개 생균제 사용에 적합한 유산균주의 선발 및 면역활성 평가

  • Park, Su-Min (College of Veterinary Medicine, Chungbuk National University) ;
  • Park, Ho-Eun (College of Veterinary Medicine, Chungbuk National University) ;
  • Lee, Wan-Kyu (College of Veterinary Medicine, Chungbuk National University)
  • Received : 2015.04.08
  • Accepted : 2015.05.07
  • Published : 2015.06.30


This study was conducted to isolate lactic acid bacteria (LAB) from dog intestine and identify potential probiotic strains for canine use. One hundred and one LAB were isolated from feces of 20 healthy dogs. Acid, bile, and heat resistance along with adherence to Caco-2 cells and antimicrobial activity against pathogens were examined. To analyze immunomodulative effects, the production of nitric oxide (NO), TNF-${\alpha}$, and IL-$1{\beta}$ was measured using RAW 264.7 macrophages. Additionally, RAW BLUE cells were used to evaluate nuclear factor-${\kappa}B$ (NF-${\kappa}B$) generation. Ultimately, three strains were selected as canine probiotics and identified as Lactobacillus reuteri L10, Enterococcus faecium S33, and Bifidobacterium longum B3 by 16S rRNA sequence analysis. The L10 and S33 strains showed tolerance to pH 2.5 for 2 h, 1.0% Oxgall for 2 h, and $60^{\circ}C$ for 5 min. These strains also had strong antimicrobial activity against Escherichia coli KCTC 1682, Salmonella Enteritidis KCCM 12021, Staphylococcus aureus KCTC 1621, and Listeria monocytogenes KCTC 3569. All three strains exerted better immunomodulatory effects than Lactobacillus rhamnosus GG (LGG), a well-known commercial immunomodulatory strain, based on NO, NF-${\kappa}B$, IL-$1{\beta}$, and TNF-${\alpha}$ production. These results suggested that the three selected strains could serve as canine probiotics.


  1. Zinedine A, Faid M. Isolation and characterization of strains of Bifidobacteria with probiotic proprieties in vitro. World J Dairy Food Sci 2007, 2, 28-34.
  2. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 1994, 35, 483-489.
  3. Ahn SB, Park HE, Lee SM, Kim SY, Shon MY, Lee WK. Characteristics and immuno-modulatory effects of Weissella cibaria JW15 isolated from Kimchi, Korea traditional fermented food, for probiotic use. J Biomed Res 2013, 14, 206-211.
  4. Beasley SS, Manninen TJK, Saris PEJ. Lactic acid bacteria isolated from canine faeces. J Appl Microbiol 2006, 101, 131-138.
  5. Brandao RL, Castro IM, Bambirra EA, Amaral SC, Fietto LG, Tropia MJM, Neves MJ, Dos Santos RG, Gomes NCM, Nicoli JR. Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Environ Microbiol 1998, 64, 564-8.
  6. Byun JW, Kim GT, Bae HS, Baek YJ, Lee WK. In vitro selection of lactic acid bacteria for probiotic use in pigs. Korean J Vet Res 2000, 40, 701-706.
  7. Cato AC, Wade E. Molecular mechanisms of antiinflammatory action of glucocorticoids. Bioassays 1996, 18, 371-378.
  8. Capuron L, Hauser P, Hinze-Selch D, Miller AH, Neveu PJ. Treatment of cytokine-induced depression. Brain Behav Immun 2002, 16, 575-580.
  9. Choi HJ, Kim JY, Shin MS, Lee SM, Lee WK. Immunomodulatory effects of bacteriocin-producing Pediococcus pentosaceus JWS 939 in Mice. Korean J Food Sci Anim Resour 2011, 31, 719-729.
  10. Collington GK, Parker DS, Armstrong DG. The influence of inclusion of either an antibiotic or a probiotic in the diet on the development of digestive enzyme activity in the pig. Br J Nutr 1990, 64, 59-70.
  11. Derouich-Guergour D, Brenier-Pinchart MP, Ambroise-Thomas P, Pelloux H. Tumour necrosis factor ${\alpha}$ receptors: role in the physiopathology of protozoan parasite infections. Int J Parasitol 2001, 31, 763-769.
  12. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996, 87, 2095-2147.
  13. Fleming HP, Etchells JL, Costilow RN. Microbial inhibition by an isolate of Pediococcus from cucumber brines. Appl Microbiol 1975, 30, 1040-1042.
  14. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989, 66, 365-378.
  15. Handl S, Dowd SE, Garcia-Mazcorro JF, Steiner JM, Suchodolski JS. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS Microbiol Ecol 2011, 76, 301-310.
  16. Introna M, Breviario F, d'niello EM, Golay J, Dejana E, Mantovani A. IL-1 inducible genes in human umbilical vein endothelial cells. Eur Heart J 1993, 14 (Suppl K), 78-81.
  17. Jordan KN, Cogan TM. Heat resistance of Lactobacillus spp. isolated from Cheddar cheese. Lett Appl Microbiol 1999, 29, 136-140.
  18. Kimoto H, Kurisaki J, Tsuji NM, Ohmomo S, Okamoto T. Lactococci as probiotic strains: adhesion to human enterocytelike Caco-2 cells and tolerance to low pH and bile. Lett Appl Microbiol 1999, 29, 313-316.
  19. Lim HJ, Kim SY, Lee WK. Isolation of cholesterol-lowering lactic acid bacteria from human intestine for probiotic use. J Vet Sci 2004, 5, 391-395.
  20. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 1993, 268, 12231-12234.
  21. Mitsuoka T. A Color Atlas of Anaerobic Bacteria. 1st ed. pp. 45-54, Sobunsha, Tokyo, 1980.
  22. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992, 6, 3051-3064.
  23. Pato U. Bile and acid tolerance of lactic acid bacteria isolated from dadih and their antimutagenicity against mutagenic heated tauco. Asian-Australas J Anim Sci 2003, 16, 1680-1685.
  24. Perdigon G, de Macias ME, Alvarez S, Oliver G, de Ruiz Holgado AP. Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 1988, 63, 17-23.
  25. Perelmuter KM, Fraga M, Zunino P. In vitro activity of potential probiotic Lactobacillus murinus isolated from the dog. J Appl Microbiol 2008, 104, 1718-1725.
  26. Ryu JS, Han SK, Shin MS, Lee WK. In vitro selection of lactic acid bacteria for probiotic use in pig. Korean J Vet Serv 2009, 32, 33-41.
  27. Sahadeva RPK, Leong SF, Chua KH, Tan CH, Chan HY, Tong EV, Wong SYW, Chan HK. Survival of commercial probiotic strains to pH and bile. Int Food Res J 2011, 18, 1515-1522.
  28. Shin MS, Han SK, Ji AR, Ham MR, Kim KS, Lee WK. Isolation and characteristics of bacteriocin-producing bacteria from the intestine of duck for probiotics. J Anim Sci Technol 2007, 49, 621-632.
  29. Simpson PJ, Stanton C, Fitzgerald GF, Ross RP. Intrinsic tolerance of Bifidobacterium species to heat and oxygen and survival following spray drying and storage. J Appl Microbiol 2005, 99, 493-501.
  30. Snyder SH, Bredt DS. Biological roles of nitric oxide. Sci Am 1992, 266, 68-77.
  31. Strompfova V, Marci akova M, Simonova M, Bogovi - Matijas B, Laukova A. Application of potential probiotic Lactobacillus fermentum AD1 strain in healthy dogs. Anaerobe 2006, 12, 75-79.
  32. Strompfova V, Laukova A, Ouwehand AC. Selection of enterococci for potential canine probiotic additives. Vet Microbiol 2004, 100, 107-114.
  33. Tadesse G, Ephraim E, Ashenafi M. Assessment of the antimicrobial activity of lactic acid bacteria isolated from Borde and Shamita, traditional Ethiopian fermented beverages, on some food borne pathogens and effect of growth medium on the inhibitory activity. Internet J Food Saf 2005, 5, 13-20.
  34. Vandenbergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 1993, 12, 221-237.
  35. Wold AE. Immune effects of probiotics. Scand J Nutr 2001, 45, 76-85.